Vertex Pharmaceuticals (VRTX) Enterprise Value Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.86% |
| Dec 31, 2025 | -8.05% |
| Sep 30, 2025 | 3.64% |
| Jun 30, 2025 | -10.13% |
| Mar 31, 2025 | 39.03% |
| Dec 31, 2024 | 45.48% |
| Sep 30, 2024 | 45.30% |
| Jun 30, 2024 | 48.42% |
| Mar 31, 2024 | 2.33% |
| Dec 31, 2023 | -4.08% |
| Sep 30, 2023 | -22.08% |
| Jun 30, 2023 | -21.43% |
| Mar 31, 2023 | -26.41% |
| Dec 31, 2022 | -43.24% |
| Sep 30, 2022 | -40.37% |
| Jun 30, 2022 | -37.95% |
| Mar 31, 2022 | -18.98% |
| Dec 31, 2021 | -13.01% |
| Sep 30, 2021 | -13.17% |
| Jun 30, 2021 | -23.07% |
| Mar 31, 2021 | -65.23% |
| Dec 31, 2020 | -74.85% |
| Sep 30, 2020 | -53.92% |
| Jun 30, 2020 | -37.95% |
| Mar 31, 2020 | -20.48% |
| Dec 31, 2019 | -20.20% |
| Sep 30, 2019 | -32.00% |
| Jun 30, 2019 | -44.25% |
| Mar 31, 2019 | -42.12% |
| Dec 31, 2018 | -52.69% |
| Sep 30, 2018 | -68.19% |
| Jun 30, 2018 | -85.99% |
| Mar 31, 2018 | -816.98% |
| Dec 31, 2017 | -65.60% |
| Sep 30, 2017 | -91.16% |
| Jun 30, 2017 | -66.60% |
| Mar 31, 2017 | 69.20% |
| Dec 31, 2016 | -40.97% |
| Sep 30, 2016 | -10.62% |
| Jun 30, 2016 | -2.40% |
| Mar 31, 2016 | 25.31% |
| Dec 31, 2015 | 34.93% |
| Sep 30, 2015 | 42.40% |
| Jun 30, 2015 | 29.20% |
| Mar 31, 2015 | 12.40% |
| Dec 31, 2014 | 6.77% |
| Sep 30, 2014 | -19.13% |
| Jun 30, 2014 | 12.38% |
| Mar 31, 2014 | -26.41% |
| Dec 31, 2013 | -30.28% |
| Sep 30, 2013 | 1.57% |
| Jun 30, 2013 | -17.38% |
| Mar 31, 2013 | 7.26% |
| Dec 31, 2012 | -35.93% |
| Sep 30, 2012 | -131.54% |
| Mar 31, 2012 | -37.17% |
| Dec 31, 2011 | 19.79% |
| Sep 30, 2011 | 54.76% |
| Mar 31, 2011 | 24.64% |
| Dec 31, 2010 | 19.73% |
| Sep 30, 2010 | -115.16% |
| Jun 30, 2010 | -139.43% |
| Mar 31, 2010 | -81.45% |